Figure 5
Correlation between the numbers of CD26+ SCs and CML scores. (A-B) In 27 patients with CML (BM samples, n = 26; PB, n = 1), the percentage of CD26+ SC (of all CD34+/CD38− cells) and CD26+ progenitor cells (of all CD34+/CD38+ cells) was determined by flow cytometry. Percentage of CD26+ SC (left) and CD26+ progenitor cells (right subpanel) in various categories of the Sokal score (A) and Hasford score (B). In high-risk patients, phenotypically more mature progenitor cells tend to acquire CD26. Sokal scoring: high (>1.2), intermediate (int) (0.8-1.2), and low (<0.8). Hasford scoring: high (>1480), int (781-1480), low (≤780). (C) Correlations between the percentages of CD26+ SC and the 3 scoring systems. As shown, no substantial correlation was found.

Correlation between the numbers of CD26+ SCs and CML scores. (A-B) In 27 patients with CML (BM samples, n = 26; PB, n = 1), the percentage of CD26+ SC (of all CD34+/CD38 cells) and CD26+ progenitor cells (of all CD34+/CD38+ cells) was determined by flow cytometry. Percentage of CD26+ SC (left) and CD26+ progenitor cells (right subpanel) in various categories of the Sokal score (A) and Hasford score (B). In high-risk patients, phenotypically more mature progenitor cells tend to acquire CD26. Sokal scoring: high (>1.2), intermediate (int) (0.8-1.2), and low (<0.8). Hasford scoring: high (>1480), int (781-1480), low (≤780). (C) Correlations between the percentages of CD26+ SC and the 3 scoring systems. As shown, no substantial correlation was found.

Close Modal

or Create an Account

Close Modal
Close Modal